Mid-Atlantic Claims $8.5 Billion Slice of $62 Billion North American Life Science Capital/MRO Investment Pie, an Industrial Info News Alert
(firmenpresse) - SUGAR LAND, TX -- (Marketwired) -- 10/31/14 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- There are more than 1,400 active reported Pharmaceutical-Biotech capital and maintenance (MRO) projects in North America, representing a total investment value (TIV) of nearly $62 billion. According to a recent analysis of Industrial Info's database, the region is at the top of that investment, accounting for an $8.5 billion portion of that spending divided over 176 projects.
Within this article: Details on the industry's outlook and key projects, including those from major companies such as United Therapeutics Corporation (NASDAQ:UTHR).
For details, , or browse other breaking industrial news stories at .
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, three offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "" page.
Contact:
William Ploch
713-783-5147
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 31.10.2014 - 10:15 Uhr
Sprache: Deutsch
News-ID 348624
Anzahl Zeichen: 0
contact information:
Town:
SUGAR LAND, TX
Kategorie:
Healthcare
Diese Pressemitteilung wurde bisher 265 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Mid-Atlantic Claims $8.5 Billion Slice of $62 Billion North American Life Science Capital/MRO Investment Pie, an Industrial Info News Alert"
steht unter der journalistisch-redaktionellen Verantwortung von
Industrial Info Resources (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
